--- title: "Enovix | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 9.024 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/295706270.md" datetime: "2026-08-12T20:31:58.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295706270.md) - [en](https://longbridge.com/en/news/295706270.md) - [zh-HK](https://longbridge.com/zh-HK/news/295706270.md) --- # Enovix | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 9.024 M Revenue: As of FY2026 Q2, the actual value is USD 9.024 M, beating the estimate of USD 8.431 M. EPS: As of FY2026 Q2, the actual value is USD -0.2, beating the estimate of USD -0.2053. EBIT: As of FY2026 Q2, the actual value is USD -41.91 M. ### Second Quarter 2026 Financial Highlights Enovix Corporation reported a GAAP gross profit of $1.3 million and a non-GAAP gross profit of $1.8 million, marking the seventh consecutive quarter of positive gross profit on both bases. The GAAP gross margin was 14.4%, a decrease of 11.6 percentage points year-over-year, while the non-GAAP gross margin was 19.9%, down 10.9 percentage points year-over-year. Operating expenses were $44.6 million (GAAP) and $30.6 million (non-GAAP), compared to $45.7 million (GAAP) and $28.8 million (non-GAAP) in the prior-year quarter. The company’s GAAP loss from operations was - $43.3 million, and non-GAAP loss from operations was - $28.8 million. ### Year-to-Date 2026 Financial Highlights For the first half of 2026, GAAP gross profit was $2.9 million, an increase of $0.7 million year-over-year, and non-GAAP gross profit was $3.8 million, up $1.1 million year-over-year. Year-to-date GAAP gross margin was 17.2%, down 0.3 percentage points, and non-GAAP gross margin improved to 22.8%, up 1.5 percentage points year-over-year. Operating expenses for the year-to-date were $90.0 million (GAAP) and $61.3 million (non-GAAP). The GAAP loss from operations was - $87.2 million, and non-GAAP loss from operations was - $57.5 million. ### Cash Flow Net cash used in operating activities improved to - $21.8 million in Q2 2026 from - $25.9 million in Q2 2025. Free cash flow was an outflow of - $31.4 million in Q2 2026, compared to an outflow of - $33.8 million in the prior-year quarter. For the first half of 2026, net cash used in operating activities was - $54.9 million, and free cash flow was an outflow of - $67.7 million, compared to - $42.8 million and - $57.0 million, respectively, in the first half of 2025. Capital expenditures were - $9.6 million in Q2 2026 and - $12.8 million year-to-date. Enovix Corporation ended the quarter with approximately $552.1 million in cash, cash equivalents, and marketable securities, including restricted cash. Adjusted EBITDA for Q2 2026 was - $18.9 million, compared to - $20.1 million in Q2 2025, and year-to-date Adjusted EBITDA was - $39.3 million, compared to - $40.9 million in the first half of 2025. ### Operational Metrics Enovix Corporation’s lead smartphone customer confirmed that Enovix batteries passed over 1,000 cycles under the 0.2C discharge cycle test, with the final accelerated cycle-life test for smartphone qualification currently underway and expected to be completed in 2026. The smart eyewear ramp is underway, with approximately 2,100 AI-1™ batteries shipped and initial smart eyewear revenue recognized. Third-quarter smart eyewear shipments are expected to increase approximately ninefold from the second quarter to around 19,000 packs against a 50,000-pack order. The drone, defense, and industrial pipeline grew to $183 million, an increase of approximately 41% from $130 million at the end of the first quarter, with drone opportunities alone exceeding $100 million during the second quarter. ### Outlook / Guidance For the third quarter of 2026, Enovix Corporation anticipates revenue between $9.0 million and $10.0 million, representing a year-over-year increase of approximately 13% to 25%. The company expects a non-GAAP loss from operations ranging from - $29.0 million to - $32.0 million, and non-GAAP net loss per share between - $0.13 and - $0.17. Capital expenditures for the third quarter are projected to be between $8.0 million and $12.0 million. ### Related Stocks - [ENVX.US](https://longbridge.com/en/quote/ENVX.US.md) ## Related News & Research - [Enovix to double South Korea drone battery capacity by mid-2027](https://longbridge.com/en/news/296491794.md) - [Enovix (ENVX) Q2 2026 Earnings Call: Smart Eyewear Revenue Begins, Pipeline Reaches $183M](https://longbridge.com/en/news/295901643.md) - [Cel-Sci GAAP EPS of -$0.47](https://longbridge.com/en/news/296114461.md) - [Top Kingwin Ltd GAAP EPS of -$7.70, revenue of $5.86M](https://longbridge.com/en/news/296397057.md) - [Enovix Says Strategy Intact as CFO Takes Interim CEO Role After Raj Resigns](https://longbridge.com/en/news/296150178.md)